Someone asks:
What Fidelity growth pharmaceutical mutual fund do you recommend?
Answers:
Jason P:
They only have 1: FPHAX. It hasn’t done well YTD, but its long-term performance seems decent. There are ETF options like IHE, PJP, and PPH also.
Gary H:
There are some solid companies in FPHAX. I wonder why it’s returns are relatively low. I noticed a similar oddity when comparing those 3 ETFs. It is likely due to decisions/holdings/valuations at the time the covid vaccines came out. Moderna has been very volatile in the last half of 2021.
Ernie S:
I like FSMEX. Great returns over extended period. I didn’t recognize many of the Top Ten companies in the portfolio, but the fund is clearly performing well.
Kenneth M:
I also hold FSMEX in my IRA. Started buying in in 2018 and have added twice, plus reinvesting the semiannual dividends. Up 84% vs the purchase prices.
Will C:
I like Johnson & Johnson and Merck. Especially for the vaccine.
Atticus S:
Modern has made me a nice profit. I bought them @ 40ish X 25 then sold. Re bought and 53 and have never been negative.
1 post – 1 participant